[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:gm1-gangliosidosis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":61,"states":62},"GM1 Gangliosidosis",8,6,[8,16,23,29,35,41,47,54],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT03952637","A Phase 1\u002F2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:15:40.343619Z","2026-05-05T02:43:28.473273Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07054515","A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis",[20],"Phase 3","2026-08-26T02:18:57.189473Z","2026-05-05T02:43:29.464579Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT00668187","A Natural History Study of the Gangliosidoses",[],"2026-08-26T02:19:22.562392Z","2026-05-13T02:55:06.039698Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT00029965","Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders",[],"2026-08-26T02:15:24.145250Z","2026-05-13T02:55:06.028754Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06539169","FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases",[],"2026-08-26T02:18:44.395098Z","2026-05-13T02:55:06.551987Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT03333200","Longitudinal Study of Neurodegenerative Disorders",[],"2026-08-26T02:18:51.009190Z","2026-05-13T02:55:06.121889Z",{"nct_id":48,"title":49,"phases":50,"status":51,"updated_at":52,"content_modified":53},"NCT05368038","ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program",[],"ENROLLING_BY_INVITATION","2026-08-26T02:18:52.966503Z","2026-06-16T05:54:08.030731Z",{"nct_id":55,"title":56,"phases":57,"status":58,"updated_at":59,"content_modified":60},"NCT07082543","A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T02:31:11.254845Z","2026-05-05T02:43:28.672925Z",[],[63,67],{"state":64,"count":65,"slug":66},"California",3,"california",{"state":68,"count":65,"slug":69},"Minnesota","minnesota"]